Scale -


  • Revenue is 1408 Rs Cr; Annual Growth is 51 %; in Bottom Quartile
  • Ebitda is 474 Rs Cr; Annual Growth is 44 %; Continuous Growth over 3 years; 5 Year CAGR is 14 %; in Bottom Quartile
  • PBT is 129 Rs Cr; Annual Growth is 44 %; 5 Year CAGR is 15 %
  • PAT is 327 Rs Cr; Annual Growth is 39 %; Continuous Growth over 3 years; 5 Year CAGR is 14 %; in Bottom Quartile
  • Quarterly Profit is 96.15 Rs Cr; Continuous Growth over 3 Quarters
  • Quarterly Revenue is 364 Rs Cr; Continuous Decline over 3 Quarters; in Bottom Quartile
  • Quarterly Ebitda is 99.6 Rs Cr; in Bottom Quartile

Profitability -


  • Quarterly Profit margin is 26 %; Continuous Growth over 3 Quarters; in Top Quartile
  • PBDIT Margin is 33.66 %; in Top Quartile
  • PAT Margin is 23.21 %; in Top Quartile

Return -


  • ROCE is 76.8 %; Annual Growth is 42 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 19 %
  • ROA is 38.85 %; Annual Growth is 32 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 16 %
  • ROE is 62.32 %; Annual Growth is 43 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 19 %
  • Asset Turnover is 172 %; Annual Growth is 46 %; in Top Quartile

Efficiency -


  • Inventory Turnover Ratio is 11.45; Annual Growth is 34 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 43 %
  • Operating cash flow is 338 Rs Cr; Annual Growth is 100 %; in Bottom Quartile

Solvancy -


  • Debt/Equity is 0; in Bottom Quartile
  • Total Debt is 0 Rs Cr; in Bottom Quartile
  • Contingent Liabilities is 182 Rs Cr; in Bottom Quartile

Quality -


  • Operating cashflow/ebitda is 71 %; Annual Growth is 39 %
  • Operating cashflow/PAT is 103 %; Annual Growth is 44 %
  • Change in Inventories/Total Expenses is -1 %; Annual Decline is -156 %
  • Exceptional Items/PBT is 0 %; in Top Quartile
  • Other Expenses/Total Expenses is 37 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Procter & Gamble Health Ltd. Estimates – NSE:PGHL
Procter & Gamble Health Ltd Forms Death Cross Signalling Bearish Trend
PGHH Regulation 74(5) Certificate Q2 FY27 Filing
Procter & Gamble Health (PGHL.NS) Eases 0.47% to ?5,275, Holding Above ?5,011 Support
Procter & Gamble Hygiene and Health Care (NSEI:PGHH) Stock Forecast & Analyst Predictions